{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:32:49Z","timestamp":1792801969399,"version":"4.5.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Joint Program on Rare Diseases","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["AZ 406838"],"award-info":[{"award-number":["AZ 406838"]}],"id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec013\">\n<jats:title>Background and aims<\/jats:title>\n<jats:p>Predicting progression and prognosis in Interstitial Lung Diseases (ILD), especially Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF), remains a challenge. Integrating patient-centered measurements is essential for earlier and safer detection of disease progression. Home monitoring through e-health technologies, such as spirometry and oximetry connected to smartphone applications, holds promise for early detection of ILD progression or acute exacerbations, enabling timely therapeutic interventions.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec014\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The European ILD Registry Algorithm for Self-Assessment in ILD (eurILDreg ASA-ILD), developed by all eurILDreg principal investigators, includes questionnaires on symptom burden, respiratory infections, and quality of life (EQ5D VAS, K-BILD, LCQ). The algorithm also incorporates spirometry and oxygen saturation measurements, both at rest and during exercise (one-minute sit-to-stand test, 1STST). This ASA-ILD algorithm is integrated into the patientMpower Ltd. smartphone application, used for patient-led monitoring, research, and clinical care since 2016, and available on both Apple and Android platforms.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec015\">\n<jats:title>Discussion<\/jats:title>\n<jats:p>For patient-centered measurements, participants in the multicenter eurILDreg study will receive a patientMpower account, a handheld clinical-grade spirometer (Spirobank Smart, MIR, Italy), and a pulse oximeter (Nonin Medical, Inc. Plymouth, MN, USA), along with usage instructions. Artificial intelligence software (ArtiQ) will analyze spirometry maneuvers in real-time, ensuring compliance with recent\u00a0ERS\/ATS criteria and providing automated feedback. Pulse oximetry is integrated into the exercise testing within the application, following an automated in-app protocol developed with clinician involvement for safety and accuracy. The application will send reminders to participants to complete patient-reported outcome measures (PROMs) according to the study protocol.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec016\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This study is designed to explore the potential of e-Health technologies, such as home monitoring via spirometry and oximetry, integrated with the eurILDreg ASA-ILD algorithm and patientMpower app, to improve early detection and management of ILD. A pilot trial showed promising adherence to spirometry, indicating that digital health interventions could enhance patient care and outcomes in ILD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec017\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>The ethics committee of the Justus-Liebig-University of Giessen has approved the eurILDreg and this substudy with the protocol reference number 111\/08. The research was conducted strictly according to the principles of the Declaration of Helsinki. Patients were included into the registry upon having signed the informed consent. The eurIPFreg and eurIPFbank are listed in ClinicalTrials.gov (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02951416\" xlink:type=\"simple\">NCT02951416<\/jats:ext-link>). EurILDreg is registered in <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/trialsearch.who.int\/\" xlink:type=\"simple\">German<\/jats:ext-link> Clinical Trials Register, DRKS 00028968.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0316484","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:32:20Z","timestamp":1738175540000},"page":"e0316484","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["European ILD registry algorithm for self-assessment in interstitial lung diseases (eurILDreg ASA-ILD)"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-4294","authenticated-orcid":true,"given":"Ekaterina","family":"Krauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurenz H.","family":"Claas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Wobisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael W.","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Moor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Molina-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oisin","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Borton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies S.","family":"Wijsenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik","family":"Hirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Vancheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of eurILDreg investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"10354","key":"pone.0316484.ref001","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"M Wijsenbeek","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"pone.0316484.ref002","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"G Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0316484.ref003","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"WD Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"pone.0316484.ref004","doi-asserted-by":"crossref","first-page":"104021","DOI":"10.1016\/j.lpm.2020.104021","article-title":"Diagnostic approach of fibrosing interstitial lung diseases of unknown origin","volume":"49","author":"V Cottin","year":"2020","journal-title":"Presse Med"},{"issue":"2","key":"pone.0316484.ref005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccm.2021.03.001","article-title":"Interstitial lung disease in 2020: a history of progress","volume":"42","author":"S Guler","year":"2021","journal-title":"Clin Chest Med"},{"issue":"12","key":"pone.0316484.ref006","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.3390\/ijms241210196","article-title":"Acute exacerbations of interstitial lung diseases: focus on biomarkers","volume":"24","author":"F Drakopanagiotakis","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"pone.0316484.ref007","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1164\/rccm.202007-2993OC","article-title":"The association of aging biomarkers, interstitial lung abnormalities, and mortality","volume":"203","author":"JL Sanders","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"150","key":"pone.0316484.ref008","doi-asserted-by":"crossref","first-page":"180075","DOI":"10.1183\/16000617.0075-2018","article-title":"Patients\u2019 perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases.","volume":"27","author":"J Swigris","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"1","key":"pone.0316484.ref009","doi-asserted-by":"crossref","first-page":"e001088","DOI":"10.1136\/bmjresp-2021-001088","article-title":"Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians","volume":"8","author":"M Althobiani","year":"2021","journal-title":"BMJ Open Respir Res"},{"issue":"10","key":"pone.0316484.ref010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1089\/tmj.2020.0078","article-title":"The potential for remotely mentored patient-performed home self-monitoring for new onset alveolar-interstitial lung disease","volume":"26","author":"AW Kirkpatrick","year":"2020","journal-title":"Telemed J E Health"},{"issue":"3","key":"pone.0316484.ref011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1164\/rccm.202002-0328OC","article-title":"home monitoring in patients with idiopathic pulmonary fibrosis. a randomized controlled trial","volume":"202","author":"CC Moor","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"pone.0316484.ref012","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.201511-2152OC","article-title":"Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis","volume":"194","author":"A-M Russell","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0316484.ref013","doi-asserted-by":"crossref","first-page":"2001518","DOI":"10.1183\/13993003.01518-2020","article-title":"Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial.","volume":"58","author":"I Noth","year":"2021","journal-title":"Eur Respir J"},{"issue":"8","key":"pone.0316484.ref014","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1164\/rccm.201605-0906ED","article-title":"What gets measured gets managed: daily home spirometry in idiopathic pulmonary fibrosis","volume":"194","author":"KA Johannson","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0316484.ref015","doi-asserted-by":"crossref","first-page":"1701403","DOI":"10.1183\/13993003.01403-2017","article-title":"Home spirometry for idiopathic pulmonary fibrosis: ready for prime time?","volume":"50","author":"TM Maher","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"pone.0316484.ref016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12931-018-0810-3","article-title":"A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers","volume":"19","author":"CC Moor","year":"2018","journal-title":"Respir Res"},{"issue":"1","key":"pone.0316484.ref017","doi-asserted-by":"crossref","first-page":"1602406","DOI":"10.1183\/13993003.02406-2016","article-title":"Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis","volume":"50","author":"KA Johannson","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"pone.0316484.ref018","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-2600(22)00228-4","article-title":"Home monitoring in interstitial lung diseases","volume":"11","author":"MS Wijsenbeek","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"1","key":"pone.0316484.ref019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1513\/AnnalsATS.201703-244FR","article-title":"The value and application of the 6-minute walk test in idiopathic pulmonary fibrosis","volume":"15","author":"A Brown","year":"2018","journal-title":"Ann Am Thoracic Soc"},{"key":"pone.0316484.ref020","doi-asserted-by":"crossref","first-page":"1753466618793028","DOI":"10.1177\/1753466618793028","article-title":"The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease","volume":"12","author":"J Briand","year":"2018","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"pone.0316484.ref021","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12890-024-03389-9","article-title":"Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg)","volume":"24","author":"E Krauss","year":"2024","journal-title":"BMC Pulm Med"},{"key":"pone.0316484.ref022","article-title":"European ILD Registry;","author":"A G\u00fcnther","year":"2024"},{"issue":"1","key":"pone.0316484.ref023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12931-018-0845-5","article-title":"The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis","volume":"19","author":"A Guenther","year":"2018","journal-title":"Respir Res"},{"issue":"4","key":"pone.0316484.ref024","doi-asserted-by":"crossref","first-page":"2201519","DOI":"10.1183\/13993003.01519-2022","article-title":"European respiratory society\/American thoracic society technical statement: standardisation of the measurement of lung volumes, 2023 update","volume":"62","author":"NR Bhakta","year":"2023","journal-title":"Eur Respir J"},{"issue":"1","key":"pone.0316484.ref025","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"S Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"pone.0316484.ref026","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/13993003.congress-2022.832","article-title":"Is daily home spirometry feasible in remote monitoring of interstitial lung disease","volume-title":"In: 01.04 - M-Health\/e-health","author":"C Edwards","year":"2022"},{"issue":"4","key":"pone.0316484.ref027","doi-asserted-by":"crossref","first-page":"00441","DOI":"10.1183\/23120541.00441-2021","article-title":"Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review","volume":"7","author":"MA Althobiani","year":"2021","journal-title":"ERJ Open Res"},{"issue":"3","key":"pone.0316484.ref028","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1164\/rccm.202005-1532ED","article-title":"Remote monitoring in idiopathic pulmonary fibrosis: home is where the bluetooth-enabled spirometer is","volume":"202","author":"KA Johannson","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0316484.ref029","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12931-020-01524-8","article-title":"Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study","volume":"21","author":"T Veit","year":"2020","journal-title":"Respir Res"},{"issue":"1","key":"pone.0316484.ref030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12890-023-02336-4","article-title":"Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE","volume":"23","author":"G Nakshbandi","year":"2023","journal-title":"BMC Pulm Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0316484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:32:37Z","timestamp":1738175557000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0316484"}},"subtitle":[],"editor":[{"given":"Maurizio","family":"Balbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0316484","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}